Adjuvant camrelizumab and concurrent chemoradiotherapy can improve outcomes in patients with gallbladder cancer and extrahepatic cholangiocarcinoma.

IBM z/OS 3.2 will be the cornerstone of the z17 mainframe and includes support for the Big Iron's new AI acceleration ...